Over the past 12 months, 7 insiders at ARVINAS, INC. filed 25 open-market SEC Form 4 transactions on ARVN: 2 purchases worth $495K and 23 sales worth $1.4M. Insiders have been net sellers over this period. The most recent filing was on Jun 24, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 24, 26 | Andrew SaikChief Financial Officer | SELL | 5.7K | $8.16 | $46K |
| Jun 17, 26 | Angela M CacaceChief Scientific Officer | SELL | 2.6K | $7.59 | $20K |
| May 21, 26 | Randy TeelPresident and CEO | SELL | 2.2K | $9.04 | $20K |
| May 11, 26 | Noah BerkowitzChief Medical Officer | SELL | 11.1K | $9.94 | $110K |
| May 11, 26 | Angela M CacaceChief Scientific Officer | SELL | 9.7K | $9.94 | $96K |
| May 11, 26 | David K LoomisVP, Chief Accounting Officer | SELL | 1.9K | $9.94 | $19K |
| May 11, 26 | Andrew SaikChief Financial Officer | SELL | 11.1K | $9.94 | $111K |
| May 11, 26 | Randy TeelPresident and CEO | SELL | 9.7K | $9.94 | $96K |
| Mar 18, 26 | Noah BerkowitzChief Medical Officer | SELL | 6.4K | $11.10 | $71K |
| Mar 6, 26 | Briggs MorrisonDirector | BUY | 20.0K | $13.40 | $268K |
| Feb 27, 26 | John G HoustonDirector | SELL | 18.8K | $13.24 | $249K |
| Feb 23, 26 | Angela M CacaceChief Scientific Officer | SELL | 2.6K | $12.16 | $31K |
| Feb 23, 26 | David K LoomisChief Accounting Officer | SELL | 1.1K | $12.16 | $13K |
| Feb 23, 26 | Randy TeelPresident and CEO | SELL | 3.7K | $12.16 | $46K |
| Feb 13, 26 | Noah BerkowitzChief Medical Officer | SELL | 5.7K | $11.89 | $68K |
| Feb 13, 26 | Angela M CacaceChief Scientific Officer | SELL | 4.6K | $11.89 | $55K |
| Feb 13, 26 | David K LoomisChief Accounting Officer | SELL | 1.0K | $11.89 | $12K |
| Feb 13, 26 | Andrew SaikChief Financial Officer | SELL | 5.1K | $11.89 | $61K |
| Feb 13, 26 | Randy TeelPresident and CEO | SELL | 4.4K | $11.89 | $52K |
| Nov 7, 25 | David K LoomisChief Accounting Officer | SELL | 230 | $9.89 | $2K |
| Sep 22, 25 | Briggs MorrisonDirector | BUY | 30.0K | $7.57 | $227K |
| Jun 24, 25 | Andrew SaikChief Financial Officer | SELL | 5.7K | $7.61 | $43K |
| Jun 17, 25 | Angela M CacaceChief Scientific Officer | SELL | 2.6K | $7.49 | $19K |
| Mar 18, 25 | Noah BerkowitzChief Medical Officer | SELL | 8.7K | $8.59 | $74K |
| Feb 24, 25 | Angela M CacaceChief Scientific Officer | SELL | 3.1K | $16.75 | $51K |
| Feb 24, 25 | John G HoustonPresident and CEO | SELL | 26.2K | $16.75 | $439K |
| Feb 24, 25 | David K LoomisChief Accounting Officer | SELL | 1.2K | $16.75 | $20K |
| Feb 24, 25 | Ian TaylorPresident, R&D | SELL | 7.4K | $16.75 | $123K |
| Nov 7, 24 | David K LoomisChief Accounting Officer | SELL | 231 | $27.69 | $6K |
| Feb 23, 24 | Sean A CassidyChief Financial Officer | SELL | 1.7K | $47.05 | $80K |
| Feb 23, 24 | John G HoustonPresident and CEO | SELL | 5.2K | $47.05 | $244K |
| Feb 23, 24 | Ronald PeckChief Medical Officer | SELL | 1.7K | $47.05 | $80K |
| Feb 23, 24 | Ian TaylorChief Scientific Officer | SELL | 1.7K | $47.05 | $80K |
| Nov 8, 23 | David K LoomisChief Accounting Officer | SELL | 229 | $17.05 | $4K |
| Aug 11, 23 | Ronald PeckChief Medical Officer | SELL | 1.3K | $24.39 | $32K |
| Mar 1, 23 | Sean A CassidyChief Financial Officer | SELL | 1.7K | $29.53 | $52K |
| Mar 1, 23 | John G HoustonPresident and CEO | SELL | 5.9K | $29.53 | $174K |
| Mar 1, 23 | Ian TaylorChief Scientific Officer | SELL | 1.1K | $29.53 | $31K |
| Aug 12, 22 | Ronald PeckChief Medical Officer | SELL | 1.3K | $68.99 | $87K |
| Apr 14, 22 | Briggs MorrisonDirector | SELL | 10.8K | $67.03 | $721K |
| Mar 11, 22 | Sean A CassidyChief Financial Officer | SELL | 15.0K | $70.00 | $1.1M |
| Mar 4, 22 | Sean A CassidyChief Financial Officer | SELL | 1.6K | $63.94 | $102K |
| Mar 4, 22 | John G HoustonPresident and CEO | SELL | 6.0K | $63.94 | $385K |
| Mar 4, 22 | Ian TaylorChief Scientific Officer | SELL | 869 | $63.94 | $56K |
| Feb 15, 22 | Ian TaylorChief Scientific Officer | SELL | 5.9K | $76.58 | $421K |
| Jan 14, 22 | Briggs MorrisonDirector | SELL | 9.9K | $67.69 | $638K |
| Dec 30, 21 | Ronald PeckChief Medical Officer | SELL | 11.4K | $80.96 | $914K |
| Dec 17, 21 | Sean A CassidyChief Financial Officer | SELL | 15.0K | $70.00 | $1.1M |
| Dec 16, 21 | Liam RatcliffeDirector | SELL | 48.5K | $69.66 | $3.4M |
| Dec 15, 21 | Liam RatcliffeDirector | SELL | 67.5K | $67.46 | $4.5M |
Over the past 12 months, insiders at ARVINAS, INC. filed 2 open-market purchases worth $495K and 23 sales worth $1.4M on ARVN, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 24, 26.
The largest recent open-market ARVN insider purchase in our data was $268K by Briggs Morrison, Director, filed on Mar 6, 26.
7 different insiders at ARVINAS, INC. filed open-market SEC Form 4 transactions on ARVN over the last 12 months.
InsiderTape plots every ARVN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ARVINAS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →